SG49749A1 - Formulations containing unsaturated fatty acids - Google Patents

Formulations containing unsaturated fatty acids

Info

Publication number
SG49749A1
SG49749A1 SG1996004687A SG1996004687A SG49749A1 SG 49749 A1 SG49749 A1 SG 49749A1 SG 1996004687 A SG1996004687 A SG 1996004687A SG 1996004687 A SG1996004687 A SG 1996004687A SG 49749 A1 SG49749 A1 SG 49749A1
Authority
SG
Singapore
Prior art keywords
fatty acids
unsaturated fatty
formulations containing
containing unsaturated
formulations
Prior art date
Application number
SG1996004687A
Other languages
English (en)
Inventor
David Frederick Horrobin
Mehar Singh Manku
Austin Mcmordie
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of SG49749A1 publication Critical patent/SG49749A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996004687A 1993-01-27 1994-01-27 Formulations containing unsaturated fatty acids SG49749A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939301629A GB9301629D0 (en) 1993-01-27 1993-01-27 Formulations containing unsaturated fatty acids

Publications (1)

Publication Number Publication Date
SG49749A1 true SG49749A1 (en) 1998-06-15

Family

ID=10729428

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004687A SG49749A1 (en) 1993-01-27 1994-01-27 Formulations containing unsaturated fatty acids

Country Status (13)

Country Link
US (1) US5466841A (no)
EP (1) EP0609078A1 (no)
JP (1) JPH06293785A (no)
KR (1) KR940018091A (no)
CN (1) CN1097124A (no)
AU (1) AU671329B2 (no)
CA (1) CA2114349A1 (no)
GB (1) GB9301629D0 (no)
MY (1) MY110470A (no)
NO (1) NO304982B1 (no)
NZ (1) NZ250768A (no)
SG (1) SG49749A1 (no)
ZA (1) ZA94587B (no)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
FR2721481B1 (fr) * 1994-06-27 1996-09-06 Inst Rech Biolog Sa Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel.
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
US6153653A (en) * 1997-11-26 2000-11-28 Protarga, Inc. Choline compositions and uses thereof
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
WO2000009138A1 (fr) * 1998-08-12 2000-02-24 Morinaga Milk Industry Co., Ltd. Compositions a finalite nutritionnelle pour prevenir ou traiter l'hyperlipoproteinemie
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
AU2002230993B2 (en) 2000-12-29 2006-02-02 Alkermes, Inc. Particles for inhalation having sustained release properties
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US7816398B2 (en) 2001-03-23 2010-10-19 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
EP1427407A4 (en) 2001-03-23 2005-05-11 Luitpold Pharm Inc CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
WO2003011873A2 (en) 2001-07-27 2003-02-13 Neptune Technologies & Bioressources Inc. Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
AU2002346472A1 (en) * 2001-11-20 2003-06-10 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
DK1455755T3 (da) * 2001-11-20 2013-07-15 Civitas Therapeutics Inc Forbedrede partikelsammensætning til levering i lunge
US20100111927A1 (en) * 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
MXPA05008216A (es) * 2003-01-31 2005-10-05 Procter & Gamble Medios para mejorar la apariencia del tejido queratinoso mamifero.
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
KR20050036012A (ko) * 2003-10-14 2005-04-20 (주) 켐포트 장쇄고도불포화지방산을 함유하는 인지질조성물 및 이의 제조방법
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
IL158553A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Method for preparing phosphatidylserine containing omega-3 acid moieties
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
EP1742619A2 (en) * 2004-05-07 2007-01-17 The President and Fellows of Harvard College Pulmonary malarial vaccine
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
JP4785036B2 (ja) * 2005-06-07 2011-10-05 出光興産株式会社 ヒト細胞の分化促進剤及びそれを含む製品
KR100856938B1 (ko) * 2006-04-28 2008-09-05 재단법인서울대학교산학협력재단 불포화 고급지방산의 페길화 방법
JP5090143B2 (ja) * 2006-11-29 2012-12-05 富士化学工業株式会社 皮膚外用組成物
CA2682068C (en) 2007-03-28 2017-11-28 Aker Biomarine Asa Bioeffective krill oil compositions
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
CA2779162C (en) 2009-10-29 2018-02-06 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
JP2017512183A (ja) 2014-02-13 2017-05-18 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
EP3256003B1 (en) 2015-02-11 2022-11-09 Aker Biomarine Antarctic AS Lipid extraction processes
BR112017017310B1 (pt) 2015-02-11 2022-07-26 Aker Biomarine Antarctic As Composições lipídicas e suplemento alimentar ou nutricional, alimento médico ou funcional e veículo de liberação oral compreendendo as ditas composições
EP3737676B1 (en) 2018-01-09 2024-03-06 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
KR102076314B1 (ko) * 2018-07-16 2020-02-11 (주) 에프엔지리서치 녹용에서 분리한 신규 화합물 및 이의 약학적 용도
CN109880858B (zh) * 2019-03-18 2022-05-06 威海深蓝奇迹生物科技有限公司 一种降低海洋磷脂中游离脂肪酸含量的方法
CN110564786B (zh) * 2019-08-02 2022-06-03 大渔华创(广州)海洋生物科技有限公司 一种epa/dha型溶血磷脂组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577446A (en) * 1968-09-09 1971-05-04 American Home Prod Phosphatidylalkanolamine derivatives
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
DE3347269A1 (de) * 1983-12-28 1985-07-11 Pearson & Co (GmbH & Co), 5000 Köln Pharmazeutisch wirksame lecithine mit polyungesaettigten fettsaeuren
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
JPH03501850A (ja) * 1987-10-29 1991-04-25 ボード　オブ　リージェンツ　オブ　ザ　ユニバーシティ　オブ　ワシントン 本態性高血圧症に関連する因子
JPH01311087A (ja) * 1988-06-10 1989-12-15 Nippon Oil & Fats Co Ltd ホスファチジルコリンの製造方法
IT1230142B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana
JPH03153628A (ja) * 1989-11-13 1991-07-01 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸含有脂質の可溶化組成物

Also Published As

Publication number Publication date
GB9301629D0 (en) 1993-03-17
MY110470A (en) 1998-05-30
JPH06293785A (ja) 1994-10-21
ZA94587B (en) 1994-09-09
NZ250768A (en) 1995-12-21
CA2114349A1 (en) 1994-07-28
NO940288D0 (no) 1994-01-27
NO940288L (no) 1994-07-28
US5466841A (en) 1995-11-14
KR940018091A (ko) 1994-08-16
EP0609078A1 (en) 1994-08-03
AU671329B2 (en) 1996-08-22
AU5474994A (en) 1994-08-04
NO304982B1 (no) 1999-03-15
CN1097124A (zh) 1995-01-11

Similar Documents

Publication Publication Date Title
SG49749A1 (en) Formulations containing unsaturated fatty acids
GR910100276A (en) Antimicrobiac compositions of fatty acids
PH29944A (en) Washing composition constaining fatty acid esters
ZA895512B (en) Fatty acid composition
SI0823895T1 (en) Fatty acid esters as bioactive compounds
ZA926133B (en) Imidazolyl-alkenoic acids
EP0730447A4 (en) FATTY ACID DIFFUSION PROCESS
IL103932A (en) Fatty acid and pharmaceutical compositions containing them
GB9325558D0 (en) Percaboxylic acids
AU659456B2 (en) Fatty acid treatment
ZA931389B (en) Process for obtaining unsaturated fatty acids.
GB2255406B (en) Quantitative assay for fatty acids
AU5574094A (en) Polyunsaturated fatty acyl-peptide composition
GB9124969D0 (en) Fatty ester hydrogenation
GB9620248D0 (en) Esters of unsaturated fatty acids
ZA895758B (en) Polyunsaturated fatty acids
GB9621293D0 (en) Formulations containing unsaturated fatty acids
AU1289995A (en) Non-methylene interrupted fatty acids as immunomodulators
GB9805123D0 (en) Presentation of fatty acids
AU2967689A (en) Fatty acid monoethanolamide containing detergents
AU3645195A (en) Modified polyunsaturated fatty acids
GB9317568D0 (en) Reduced absorption of fatty acids
ZA933757B (en) Cyclopentane-and-pentene-beta-amino acids
GB9517434D0 (en) Essential fatty acid compositions
GB9407641D0 (en) Essential fatty acid supplements